Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Affordable, afforded, bearing, Biotechnol, bleeding, born, cancelable, capturing, characteristic, chemoradiotherapy, commitment, committed, conclusion, curtail, Dec, deferral, Dendreon, dilly, discontinue, dropped, enterprise, envisioned, Epub, fulfillment, GBM, Gilead, hemophila, hierarchy, immunotherapy, inBlood, inclusion, ineffective, injured, innovative, insufficiency, insufficient, IX, Jun, Lastly, leukemia, leveraged, lifelong, load, lymphoma, manual, maximum, minimal, MMT, modest, mouse, multidisciplinary, narrowed, Nat, neovascularization, older, oxygen, potent, procuring, properly, rare, rat, recruited, replicate, residing, Rigel, ringo, round, SAGETM, score, sNCV, Southern, standard, step, stephen, strain, strength, symptomatic, Takeda, TALE, transplant, transplantation, understood, unmet, updated, view, VIII
Removed:
activating, actively, American, attempt, backed, beneficially, billion, biotech, bought, branded, calculation, collateralized, concentration, connected, crop, Cystic, declining, Defense, delaying, delinquency, disclosed, discount, diversify, diversifying, efficient, effort, facilitate, financed, generating, home, housing, indirect, led, limiting, man, Medarex, Medimmune, midpoint, Millennium, mitigate, monitor, mortgage, mutually, neovasculariztion, nutritional, operated, opted, Placement, premium, preventing, Proc, processing, requiring, resale, residential, simplified, subprime, supplying, undergoing
Filing tables
Filing exhibits
- 10-K Annual report
- 10.49 Seventh Amendment of the Research and Commercial License Option Agreement
- 10.50 Letter Agreement Amendment Regarding the Research and Commercial License Option
- 23.1 Consent of Independent Registered Public Accounting Firm
- 31.1 Rule 13A-14(A) Certification of Chief Executive Officer
- 31.2 Rule 13A-14(A) Certification of Principal Financial Officer
- 32.1 Certification Pursuant to 18 U.s.c. Section 1350
Related press release
SGMO similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements (Form S-8 No. 333-166220, 333-157733, 333-34196, 333-64642 and 333-132823) and in the Registration Statement (Form S-3 No. 333-157732) and in the related prospectuses of Sangamo BioSciences, Inc. of our reports dated February 16, 2011, with respect to the consolidated financial statements of Sangamo BioSciences, Inc., and the effectiveness of internal control over financial reporting of Sangamo BioSciences, Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2010.
/s/ ERNST & YOUNG LLP
Palo Alto, California
February 16, 2011